Parosteal adipocytic tumors of the bone are extremely rare. As a result, (cyto-) genetic data on this entity are essentially lacking. In the literature there is debate as to whether these lesions should be classified according to the criteria used in soft-tissue tumor pathology, or if they should be considered a separate bone tumor entity. Here we present a 68-year-old male patient with a tumor in his right upper leg diagnosed as parosteal atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLS) on the basis of clinico-radiologic and pathologic findings. Molecular cytogenetic investigations using combined binary ratio labeling fluorescence in situ hybridization and array comparative genomic hybridization showed abnormalities, which are in accordance with the histologic appearance of an atypical lipomatous tumor/well-differentiated liposarcoma. Therefore, on the basis of these molecular cytogenetic investigations, we conclude that parosteal liposarcoma is not a separate entity but should be categorized within the spectrum of soft-tissue ALT/WDLS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2007.03.012DOI Listing

Publication Analysis

Top Keywords

atypical lipomatous
12
molecular cytogenetic
12
parosteal liposarcoma
8
comparative genomic
8
genomic hybridization
8
lipomatous tumor/well-differentiated
8
tumor/well-differentiated liposarcoma
8
cytogenetic investigations
8
parosteal
4
liposarcoma differ
4

Similar Publications

Liposarcomas are the most common soft tissue sarcoma primarily originating in deep soft tissues and the retroperitoneum. Sarcoma classification includes atypical lipomatous tumor/well-differentiated liposarcoma (WDL) and dedifferentiated liposarcoma (DDL), myxoid liposarcoma, and pleomorphic liposarcoma. DDL is most prevalent in the retroperitoneum and often has two distinct components, a well-differentiated lipomatous component and a dedifferentiated nonlipomatous component that could be morphologically similar to malignant fibrous histiocytoma (MFH) or fibrosarcoma.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the epidemiology of patients with musculoskeletal tumors treated at a reference hospital from 2009 to 2022.
  • A total of 1978 patients were examined, revealing that 1477 (74.67%) had sarcomas, categorized into 446 bone tumors and 1,031 soft tissue tumors.
  • The findings highlighted the most common tumors, including enchondroma for benign bone tumors, osteosarcoma for malignant, lipomas for benign soft tissue tumors, and sarcomas of uncertain differentiation as the most frequent malignant soft tissue tumors.
View Article and Find Full Text PDF

Sarcomas are a heterogeneous group of neoplasms that develop from bone and soft tissue. Approximately 80% of sarcomas affect soft tissue, with liposarcoma being one of the most common types, accounting for approximately 13-20% of all soft-tissue sarcomas. Per the World Health Organization, liposarcoma can be broadly classified into four different subtypes based on histologic examination: well-differentiated liposarcoma (WDLS)/atypical lipomatous tumors (ALT), dedifferentiated liposarcoma (DDLS), myxoid liposarcoma (MLS), and pleomorphic liposarcoma (PLS).

View Article and Find Full Text PDF
Article Synopsis
  • Lipomatous tumors are the most common soft tissue neoplasms, and distinguishing between benign lipomas and more serious atypical lipomatous tumors requires accurate diagnostic methods, including MDM2/CDK4 immunostaining.
  • In a study involving 109 patients, only a small fraction of those diagnosed with atypical tumors tested positive for MDM2, indicating that traditional morphological diagnoses may be unreliable.
  • The study highlighted that certain clinical features, such as older patient age and larger tumor size, could help identify potential atypical tumors, even though the overall accuracy of the diagnostic methods assessed was not very high.
View Article and Find Full Text PDF

Introduction And Importance: Atypical lipomatous tumor/well differentiated liposarcoma (ATL/WDL) is an intermediate, locally aggressive malignant mesenchymal neoplasm composed either entirely or in part of a mature adipocytic proliferation showing significant variation in cell size and at least focal nuclear atypia in both adipocytes and stromal cells. Symptoms related to these tumors depend on the anatomic site.

Case Presentation: A 61-year-old female presented with a long-standing worsening abdominal distension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!